Upgrade to SI Premium - Free Trial

BioNTech (BNTX) PT Raised to $143 at BMO Capital

March 11, 2025 8:57 AM
BMO Capital analyst Evan David Seigerman raised the price target on BioNTech (NASDAQ: BNTX) to $143.00 (from $130.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles